Skip to main content
main-content

01.06.2014 | Author Disclosure Summary | Sonderheft 3/2014

Annals of Surgical Oncology 3/2014

Japanese Society of Gastroenterological Surgery Article Series Disclosure Index

Zeitschrift:
Annals of Surgical Oncology > Sonderheft 3/2014
The Annals of Surgical Oncology ensures balance, independence, objectivity, and scientific rigor in all its published articles. Authors are expected to disclose any significant financial interest or other relationship(s) involving themselves with any proprietary entity producing health care goods or services related to the content of the article (Table  1).
Table 1
Disclosure index for Japanese Society of Gastroenterological Surgery article series
Article title
Lead author
Disclosure
Usefulness of Contrast-Enhanced Intraoperative Ultrasound in Identifying Disappearing Liver Metastases from Colorectal Carcinoma After Chemotherapy
Junichi Arita, MD, PhD
Disclosure. Junichi Arita, Yoshihiro Ono, Michiro Takahashi, Yosuke Inoue, Yu Takahashi, and Akio Saiura have no commercial interest in the subject of study and the source of any financial or material support
Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival
Toru Beppu, MD, PhD, FACS
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
Quality of Surgery for Stage III Colon Cancer: Comparison Between England, Germany, and Japan
Hirotoshi Kobayashi, MD
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
Pulmonary Metastasectomy Secondary to Esophageal Carcinoma: Long-Term Survival and Prognostic Factors
Nao Kobayashi, MD
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
Comparison of the Therapeutic Outcomes Between Surgical Resection and Percutaneous Ablation for Small Hepatocellular Carcinoma
Kiyoshi Hasegawa, MD, PhD
Disclosure. Kiyoshi Hasegawa, Taku Aoki, Takeaki Ishizawa, Junichi Kaneko, Yoshihiro Sakamoto, Yasuhiko Sugawara, and Nor- ihiro Kokudo have no conflicts of interest and nothing to disclose
Long-Term Clinical and Functional Results of Intersphincteric Resection for Lower Rectal Cancer
Motoi Koyama, MD
Disclosure. This study received no financial support
Profiling of Autoantibodies in Sera of Pancreatic Cancer Patients
Yosuke Nagayoshi, MD
Disclosure. Yosuke Nagayoshi, Masafumi Nakamura, Kazu- hiro Matsuoka, Takao Ohtsuka, Yasuhisa Mori, Hiroshi Kono, Teppei Aso, Noboru Ideno, Shunichi Takahata, Akihide Ryo, Hiroyuki Takeda, Tetsuhide Ito, Yoshinao Oda, Yaeta Endo, Tatsuya Sawasaki, and Masao Tanaka have no conflicts of interest directly relevant to the content of this article
Expression Analysis of THOP1 in Background Liver, a Prognostic Predictive Factor in Hepatocellular Carcinoma, Extracted by Multiarray Analysis
Shuji Nomoto, MD, PhD
Disclosure. There are no disclosures from any authors
Expressions of Hypoxia-Inducible Factor-1 and Epithelial Cell Adhesion Molecule are Linked with Aggressive Local Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Therapy
Shinichiro Yamada, MD
Disclosure. Shinichiro Yamada and co-authors have no financial interest linked to this work
CD8+ and FOXP3+ Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer
Eiji Shinto, MD
Disclosure. This work was supported in part by the National Cancer Center Research and Development Fund (23-A-11 and 23-A-26) and by Japan Society for the Promotion of Science KAKENHI (23501302 and 25462074). We certify that we do not have any commercial associations that may pose a conflict of interest in connection with this article
Preoperative Evaluation of Venous Anatomy in Laparoscopic Complete Mesocolic Excision for Right Colon Cancer
Takayuki Ogino, MD
Disclosure. Takayuki Ogino, Ichiro Takemasa, Genki Horitsugi, Mamoru Furuyashiki, Katsuya Ohta, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Tsunekazu Mizushima, Hirofumi Yamamoto, Yuichiro Doki, and Masaki Mori have no conflicts of interest or financial ties to disclose
EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma
Tatsuo Matsuda, MD
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and Changes in Body Weight are Useful Tools for Evaluation of Reconstruction Methods Following Distal Gastrectomy
Masanori Terashima, MD, PhD, FACS
Disclosure. The authors declare no conflicts of interest with regard to this manuscript
Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
Shun-ichi Ariizumi, MD
Disclosure. The authors have no commercial interests related to the subject of the study, and the study did not receive any external financial or material support
Is Preoperative Colonoscopy Necessary for Patients Undergoing Gastric Cancer Surgery?
Toshiyasu Ojima, MD
Disclosure. All authors have nothing to declare
Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study
Takaki Yoshikawa, MD, PhD
Disclosure. The authors have not declared any commercial interests related to the subject of the study nor that the study received any external financial or material support
...

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Über diesen Artikel

Weitere Artikel der Sonderheft 3/2014

Annals of Surgical Oncology 3/2014 Zur Ausgabe
  1. Sie können e.Med Chirurgie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Sie können e.Med Onkologie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise